{
  "id": "de173021a349b661",
  "title": "Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm\u2122",
  "description": "20260202T131500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/aquestive-therapeutics-announces-fda-issuance-of-complete-response-letter-for-anaphylm/2269640",
  "published_at": "20260202T131500Z",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/aquestive-therapeutics-announces-fda-issuance-of-complete-response-letter-for-anaphylm/2269640",
    "url_mobile": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/aquestive-therapeutics-announces-fda-issuance-of-complete-response-letter-for-anaphylm/2269640/amp",
    "title": "Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm\u2122",
    "seendate": "20260202T131500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/02/921441.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}